tumor tissue; normal adjacent tissue; blood plasma
-
PI3K/AKT (promotes); ceRNA regulation (other)
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis
Potential biomarker for breast cancer; elevated in tumor tissues and plasma, particularly in advanced stages and with lymph node involvement; proposed for diagnosis/prognosis and monitoring
hsa_circ_0052112 is up-regulated in breast cancer tumor tissue and plasma and is associated with advanced stage and lymph node involvement, supporting its potential as a diagnostic/prognostic biomarker. In silico analyses suggest it may act through a ceRNA network involving miR-194 and hub genes (MAPK1, STAT1, TRAF6, ERRB4) with enrichment in PI3K/AKT-related processes, and it is predicted to bind RBPs such as AGO2, EIF4A3 and PTB.
0.348
Exploring the Role of hsa_circ_0052112 as a Potential Biomarker in Breast Cancer: Insights from Experimental and In Silico Analyses.
combined biological and clinical study